Professional Summary
Professional Overview
Mark Strobeck is the President and Chief Executive Officer at Rockwell Medical, Inc., a leading pharmaceutical company focused on developing and commercializing innovative therapies for patients with kidney and iron deficiency disorders. With over 20 years of experience in the pharmaceutical industry, Mark brings a wealth of expertise in strategic leadership, operational excellence, and business development.
Experience Summary
Current Role
As the President and CEO of Rockwell Medical, Mark is responsible for driving the company's overall strategic vision and operational execution. He oversees all aspects of the business, including product development, regulatory affairs, commercial operations, and financial management. Under his leadership, Rockwell Medical has expanded its product portfolio, enhanced its manufacturing capabilities, and strengthened its position as a trusted provider of essential therapies for the renal care market.
Career Progression
Prior to joining Rockwell Medical, Mark held various executive roles at other prominent pharmaceutical companies. He served as the Managing Director at Aquilo Partners, L.P., where he provided strategic advisory services to life sciences companies. He also held the positions of Executive Vice President and Chief Operating Officer at Assertio Therapeutics and Zyla Life Sciences, as well as Chief Business Officer at Egalet Corporation, Corridor Pharmaceuticals, Topaz Pharmaceuticals, and Trevena. Earlier in his career, Mark held leadership roles at GlaxoSmithKline, where he gained extensive experience in business development and portfolio management.
Academic Background
Mark holds a Doctor of Philosophy (Ph.D.) in Biophysics from the University of Cincinnati College of Medicine and a Bachelor of Science (B.S.) in Biology from St. Lawrence University. He also attended the University of Pennsylvania School of Medicine, where he completed postgraduate studies.
Areas of Expertise
- Pharmaceutical industry leadership and strategy
- Product development and commercialization
- Regulatory affairs and quality assurance
- Business development and strategic partnerships
- Operational optimization and financial management
- Cross-functional team leadership and collaboration
Professional Impact
Throughout his career, Mark has demonstrated a strong track record of driving innovation, improving operational efficiency, and delivering value for stakeholders. He has been instrumental in the successful development and commercialization of several pharmaceutical products, contributing to improved patient outcomes and addressing unmet medical needs. Mark's industry expertise and strategic vision have been recognized by his peers, and he is actively involved in various industry associations and advisory boards.
Conclusion
With his extensive experience, proven leadership skills, and deep understanding of the pharmaceutical industry, Mark Strobeck is well-positioned to guide Rockwell Medical through its next phase of growth and expansion. As the President and CEO, he is committed to leveraging the company's capabilities to develop and commercialize innovative therapies that improve the lives of patients with kidney and iron deficiency disorders.
